share

Salicylic Acid, Compound With 3-[(1-Benzyl-1H-Indazol-3-Yl)Oxy]-N,n-Dimethylpropylamine (1:1) CAS NO 59831-61-7


Unit Price:

CAS No.:59831-61-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Salicylic Acid, Compound With 3-[(1-Benzyl-1H-Indazol-3-Yl)Oxy]-N,n-Dimethylpropylamine (1:1) is a specialized organic salt or molecular complex designed for advanced pharmaceutical research and development. This compound matters because it combines the keratolytic and anti-inflammatory properties of salicylic acid with a modified indazole pharmacophore, creating a unique chemical entity for targeted therapeutic applications. It is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing novel drug candidates, particularly in dermatology and oncology.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs).
  • Drug Discovery & Development: Used in high-throughput screening and preclinical research for potential anti-inflammatory, analgesic, or anti-proliferative agents.
  • Dermatological Research: Investigated for the development of next-generation topical formulations targeting psoriasis, acne, and other skin conditions.
  • Biochemical Research: Employed as a tool compound in enzymatic and receptor-binding studies to understand specific biological pathways.
  • Reference Standard: Utilized as an analytical standard in quality control laboratories for method development and validation.

Basic Information

Product Name Salicylic Acid, Compound With 3-[(1-Benzyl-1H-Indazol-3-Yl)Oxy]-N,n-Dimethylpropylamine (1:1)
CAS No. 59831-61-7
Molecular Formula C28H31N3O4
Molecular Weight 473.57 g/mol
Synonyms 3-[(1-Benzyl-1H-indazol-3-yl)oxy]-N,N-dimethyl-1-propanamine salicylate; 1-Propanamine, 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethyl-, salicylate (1:1); Salicylic acid - 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropylamine (1:1); N,N-Dimethyl-3-[(1-benzylindazol-3-yl)oxy]propylamine salicylate; Benzylindazole-propylamine salicylate complex
EINECS Contact for details

Quality Control

Our Salicylic Acid, Compound With 3-[(1-Benzyl-1H-Indazol-3-Yl)Oxy]-N,n-Dimethylpropylamine (1:1) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our quality commitment supports compliance with cGMP guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.